This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul P. Lee, JD, MD; Walter J. Stark, MD; Joyce C. Yang, JD

Arch Ophthalmol. 1989;107(11):1585-1589.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Penetrating keratoplasty has become one of the most successful and the most common transplant procedures in the United States, with 35 930 corneas grafted in 1987.¹ One-year survival with graft clarity is greater than 80% and is more than 90% under certain conditions.² While generally not a life-saving procedure, keratoplasty offers an opportunity for notable improvement in the quality of life for its recipients.

From the onset of the modern era in Europe during the 1930s,³ improved diagnostic and surgical techniques have expanded the utility and demand for keratoplasty. The early reports from Elschnig and Filatov detailed their experience with corneal leukomas due to burns or trauma.³ Today, the leading indication for penetrating keratoplasty is pseudophakic bullous keratopathy.⁴ As newer procedures and indications develop, the demand for donor tissue will only increase.^2,5

In 1985, a shortage of 3500 to 5000 corneas existed in the . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore, Md; New York, NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?